Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma 1 Feb, 2020 Nom de la revue European Journal of Cancer Didier Decaudin, Estelle Frisch Dit Leitz, Fariba Nemati, Malcy Tarin, Adnan Naguez, Mohamed Zerara, Benjamin Marande, Raquel Vivet-Noguer, Ensar Halilovic, Claire Fabre, Aart Jochemsen, Sergio Roman-Roman, Samar Alsafadi DOI 10.1016/j.ejca.2019.12.012 Teams / Core Facilities CurieCoreTech In vivo preclinical experiments DIDIER DECAUDIN ELISABETTA MARANGONI Translational Research Department SERGIO ROMAN ROMAN DNA Repair and Uveal Melanoma (D.R.U.M) MARC-HENRI STERN Members Image DIDIER DECAUDIN Platform Manager Image SERGIO ROMAN ROMAN Head of Translational Research Department mailwebsite Image MALCY TARIN Engineer maillinkedin